ArticleFuture oncology (London, England)2024

IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma.

Shreya Badhrinarayanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.